In our patient models, JAK1 deficiency originated from an initial chromosome 1p aberration causing mono-allelic JAK1 loss in melanoma cells and a subsequent mutation inactivating the remaining JAK1 allele. This evidence concerns the gene JAK1 and melanoma.